UBS Lifts Price Target on Pacific Biosciences of California to $12.50 From $10, Keeps Buy Rating
UBS Lifts Price Target on Pacific Biosciences of California to $12.50 From $10, Keeps Buy Rating
瑞銀將加州太平洋生物科學公司的目標股價從10美元上調至12.50美元,維持買入評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊